Editors: Supratik Rayamajhi, Prajwal Dhakal, Shiva Shrotriya, Nishraj Basnet

Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis

eBook: US $49 Special Offer (PDF + Printed Copy): US $88
Printed Copy: US $64
Library License: US $196
ISBN: 978-1-68108-785-6 (Print)
ISBN: 978-1-68108-784-9 (Online)
Year of Publication: 2021
DOI: 10.2174/97816810878491210101
(1 Comment) | Rate This Book

Introduction

Ever since the association between cancer and thrombosis was reported by Jean-Baptiste Bouillaud in the early 19th century, cancer-associated thrombosis has remained a challenging domain of cancer management. Thrombosis can at times be a lead to cancer diagnosis, while it often complicates medical situations as a coexisting disorder. In this handbook, the contributors have compiled comprehensive information on the subject to provide the reader a comprehensive review of current medical literature and guidelines for cancer-associated thrombosis.

Key Features

-clinically oriented text for application in healthcare settings

-current, evidence-based literature reviews and references

-includes guidelines on VTE prophylaxis, heparin effects and more

-includes information about special cases

Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis is an informative handbook for a broad range of readers in medicine, including generalists, residents, and graduate-level trainees.

Preface

Cancer and Thrombosis are interrelated. Their relationship adds complexity to the already challenging domain of cancer management. Thrombosis can at times be a lead to cancer diagnosis, while it often complicates the situation as a co-existing disorder.

This book is a result of generalists’ endeavor to put together a rather simpler version of compilation, as it pertains to cancer-associated thrombosis (CAT). Our product is clinically oriented as compared to some in-depth basic science coverage of preexisting books on CAT. Our primary target audience naturally remains generalists and graduate-level trainees.

We have strived to stay current in terms of literature review. Specifically, we notice a paucity of evidence-based literature on thrombosis prophylaxis among cancer patients. We hope to infuse interest among our audience through an easy read of a complex entity that includes specific clinical situations and challenges, and hopefully, a palatable end-produce.

We do not have any conflict of interest to disclose during the preparation of this book.

Supratik Rayamajhi, MD
Department of Medicine
Michigan State University
USA

RELATED BOOKS

.Current and Future Application of Artificial Intelligence in Clinical Medicine.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.
.Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem.